Legend Biotech CorporationLEGNNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-158.14M
↓ 12% below average
Average (7y)
$-141.71M
Historical baseline
Range
High:$286.66M
Low:$-416.00M
CAGR
+74.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-158.14M | +62.0% |
| 2023 | $-416.00M | -86.1% |
| 2022 | $-223.56M | +8.3% |
| 2021 | $-243.87M | +3.7% |
| 2020 | $-253.29M | -107.2% |
| 2019 | $-122.23M | -142.6% |
| 2018 | $286.66M | +8885.2% |
| 2017 | $-3.26M | - |